PhD student
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
I am a PhD candidate in the final stages of completing my doctoral dissertation, focused on exploring the genetic landscape of soft tissue sarcomas and their correlation with clinico-pathological features. My research integrates molecular biology, bioinformatics, and translational oncology to identify genomic alterations that may serve as potential therapeutic targets.
Throughout my doctoral studies, I have developed expertise in next-generation sequencing (NGS) technologies, data interpretation, and molecular diagnostics. My work involves analyzing complex genomic profiles and linking specific genetic aberrations—such as mutations, copy number variations, and gene fusions—to clinical outcomes and treatment responses. This integrative approach aims to enhance our understanding of tumor biology and contribute to more precise, personalized therapeutic strategies for cancer patients.
My scientific interests lie broadly in oncology, with particular emphasis on molecular mechanisms of tumor development, signaling pathways driving cancer progression, and resistance to therapy. I am passionate about discovering novel molecular targets and developing targeted therapies to improve the prognosis of patients with rare and aggressive malignancies.
As I approach the completion of my PhD, I am eager to continue my academic career through a postdoctoral position in a collaborative, translational research environment. I am particularly interested in projects that bridge molecular oncology, precision medicine, and functional genomics. My goal is to contribute my molecular and analytical skills to innovative research teams dedicated to transforming genomic data into clinical applications and ultimately improving patient care.